Literature DB >> 30629901

Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.

Catherine C Braga1, Randy A Taplitz1, Christopher R Flowers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30629901      PMCID： PMC6333383          DOI： 10.1200/JOP.18.00718

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  9 in total

1.  Optimal Management of Neutropenic Fever in Patients With Cancer.

Authors:  Andrea J Zimmer; Alison G Freifeld
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

2.  Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary.

Authors:  Randy A Taplitz; Erin B Kennedy; Christopher R Flowers
Journal:  J Oncol Pract       Date:  2018-09-04       Impact factor: 3.840

3.  Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update Summary.

Authors:  Randy A Taplitz; Erin B Kennedy; Christopher R Flowers
Journal:  J Oncol Pract       Date:  2018-03-08       Impact factor: 3.840

4.  Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.

Authors:  Randy A Taplitz; Erin B Kennedy; Eric J Bow; Jennie Crews; Charise Gleason; Douglas K Hawley; Amelia A Langston; Loretta J Nastoupil; Michelle Rajotte; Kenneth Rolston; Lynne Strasfeld; Christopher R Flowers
Journal:  J Clin Oncol       Date:  2018-02-20       Impact factor: 44.544

5.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Authors:  Nicole M Kuderer; David C Dale; Jeffrey Crawford; Leon E Cosler; Gary H Lyman
Journal:  Cancer       Date:  2006-05-15       Impact factor: 6.860

6.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

7.  Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.

Authors:  Randy A Taplitz; Erin B Kennedy; Eric J Bow; Jennie Crews; Charise Gleason; Douglas K Hawley; Amelia A Langston; Loretta J Nastoupil; Michelle Rajotte; Kenneth V Rolston; Lynne Strasfeld; Christopher R Flowers
Journal:  J Clin Oncol       Date:  2018-09-04       Impact factor: 44.544

8.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Authors:  J Klastersky; M Paesmans; E B Rubenstein; M Boyer; L Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; K Rolston; J Talcott
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

9.  Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.

Authors:  J A Talcott; R D Siegel; R Finberg; L Goldman
Journal:  J Clin Oncol       Date:  1992-02       Impact factor: 44.544
  9 in total
  1 in total

1.  Older patients with cancer and febrile neutropenia in the COVID-19 era: A new concern.

Authors:  Antonino C Tralongo; Martine Extermann
Journal:  J Geriatr Oncol       Date:  2020-06-18       Impact factor: 3.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.